Omicron BA.2.12.1 is still 📈 in Connecticut as it is across most of the US. Fitting the % of sequenced cases to a logistic growth curve, we estimate that BA.2.12.1:
1⃣ is ~80% frequency today (May019)
2⃣ surpassed 50% in early May
3⃣ may reach 95% in early/mid June
(2/13)
From the same logistic growth curve, we also estimate that BA.2.12.1 is:
➡️ ~24% more transmissible than background (mostly other BA.2 lineages)
➡️ doubling in proportion every ~12 days
(3/13)
Part of the fitness advantage of BA.2.12.1 (and the advantage of BA.2 over BA.1) *may* be due to enhanced intrinsic transmissibility by producing higher viral titers during infection ("brute force").
PCR CT values are not perfect, but they do support this hypothesis. (4/13)
The 📈 in BA.2.12.1 is also corresponding to a 📈 in cases, hospitalizations, and deaths in Connecticut.
Even *if* Omicron is less severe than Delta, ⬇️ immunity, ⬆️ immune escape, & ⬆️ transmissibility means that BA.2.12.1 can still have a significant population impact. (5/13)
While tracking cases is harder with at home tests, wastewater 💩🧬 testing is showing similar trends.
Virus RNA concentrations currently at early December levels when Omicron (BA.1) was just taking off. (6/13)
Potentially complicating matters is the emergence of Omicron BA.4/5.
As a reminder, the emergence of BA.4/5 was associated with a 5th COVID-19 wave in South Africa, though it is currently trending to be smaller than the previous Omicron wave. (9/13)
So far, BA.4 and BA.5 combined represent just 0.3% of the total cases from the last 3 weeks in Connecticut. Here are the totals:
Connecticut
BA.4 = 3
BA.5 = 2
United States
BA.4 = 203
BA.5 = 142
(10/13)
It's not yet clear if BA.4/5 will have a significant impact in the US. In South Africa, they emerged in a primarily BA.2 background.
In the US, the more transmissible sublineage BA.2.12.1 is becoming dominant, and it is not clear to me if BA.4/5 will have an advantage. (11/13)
If you are looking for a PCR assay to differentiate between BA.1, BA.2, and BA.4/5, ours can help! It can produce a simple genotype based on the presence/absence of 2 deletions:
P.S. Because the summer is busy with non-work things (🙏), I wont likely be able to post weekly threads, but will try to at least a couple times a month. 🏖️🍹
Based on our TaqPath PCR data (S-gene detected), we estimate that:
➡️ BA.2 is >50% in Southern Connecticut
➡️ At this rate - BA.2 will be 95% by early April
➡️ BA.2 doubling rate = 7.8 days (BA.1 in December = 3-4 days)
➡️ BA.2 ~43% more transmissible than BA.1/.1
(2/7)
Over the past 4 weeks, all of the sequenced S-gene positive samples have been Omicron BA.2 and not Delta. So we trust the 👆 PCR results reflecting the rise in BA.2. (3/7)
Here are comparative results between 10 TaqPath S-gene detected samples tested by YNHH and with our validated VOC PCR assay. Most with our assay were actually SGTF, and looking at the YNHH results, the S-gene CTs for those were 5-7 higher than N/ORF. (5/16)
We are looking into these low level spike amplification samples that should be SGTF to see if this is a lab/TaqPath assay artifact or if there is something about these BA.1 sequences. So far doesn't seem to be sequence-related. Will report (6/16)
Our initial SGTF case definition – ORF/N <30 CT, S “not detected” - was conservative to not over-call BA.1.
We updated it yesterday to include S-gene 5 CTs higher than ORF/N, and compared the results. (7/16)
We now estimate that Omicron BA.1 has remained at 98-100% of the daily tests for ~2 weeks. Meaning that Omicron BA.2 and Delta could only be a combined 0-2%.
This is different than our estimates from last week (2/16)
This next part is technical, but may be helpful to those reviewing TaqPath and sequencing data. For transparency, here was my last SGTF update that we now think was wrong. (3/16)
@maryebushman, @BillHanage & co found that variants with ⬆️ transmissibility & partial immune escape may significantly 📈 infections even in a well-💉 population.
Then along came Omicron (B.1.1.529), which was first detected in Botswana and South Africa. It rapidly became dominant, displacing Delta and others. (3/20)